Novogen Announces Breakthrough Discovery in the Treatment of Melanoma
Novogen Limited, Australian/US biotechnology company, today announces that it has confirmed that its lead candidate product, TRXE-009, originally developed for the treatment of brain cancers, has been shown in pre-clinical studies also to be highly active against melanoma.
Containing Cancer is Complicated
Why does cancer (so often) return after it's thought to have been killed and is no longer evident in the body? Scientists think they might know about why this happens - Cancer Stem Cells.
Blocking Renegade Gene Could Stop the Spread of Cancer
Blocking a rogue gene known as WWP2 has led scientists at the University of East Anglia to better understanding of how cancer spreads -- and how to stop it.